INSIDER · CIK 1614740
Peetz Christopher
CHIEF EXECUTIVE OFFICER, Director at Mirum Pharmaceuticals, Inc. (MIRM)
↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$4.9MSold on the market
1Companies
Oct 6, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 202620:38 | Oct 6, 2026 | MIRMMirum Pharmaceuticals, Inc. | CHIEF EXECUTIVE OFFICER, Director | M · Exercise | $17.31 | +12,197 | 206,637 | +6% | $211K | ||
| Sep 3, 202618:52 | Sep 1, 2026 | MIRMMirum Pharmaceuticals, Inc. | CHIEF EXECUTIVE OFFICER, Director | S · Sell10b5-1 | $98.68 | −30,000 | 194,440 | -13% | −$3.0M | ||
| Sep 3, 202618:52 | Sep 1, 2026 | MIRMMirum Pharmaceuticals, Inc. | CHIEF EXECUTIVE OFFICER, Director | M · Exercise10b5-1 | $2.94 | +30,000 | 224,440 | +15% | $88K | ||
| Aug 11, 202617:41 | Aug 10, 2026 | MIRMMirum Pharmaceuticals, Inc. | CHIEF EXECUTIVE OFFICER, Director | S · Sell10b5-1 | $98.92 | −20,000 | 194,309 | -9% | −$2.0M | ||
| Aug 11, 202617:41 | Aug 10, 2026 | MIRMMirum Pharmaceuticals, Inc. | CHIEF EXECUTIVE OFFICER, Director | M · Exercise10b5-1 | $2.94 | +20,000 | 214,309 | +10% | $59K |